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Effect of dietary omega-3 fatty acid deficiency 
on heart rate variability in hooded rats
Harrison S. Weisinger1,2, Norman Salem Jr2, Kevin K. Makino2, Joseph R. Hibbeln2, Andrew J. Sinclair3,
Richard S. Weisinger4, Paolo B. DePetrillo5
A b s t r a c t  
Introduction: Recent reports in adult humans suggest that heart rate variability
is modulated by the concentration of omega-3 polyunsaturated fatty acids (PUFA)
contained in blood cell membranes.
Material and methods: Hurst analysis of ECG data was conducted on 12 male
adult hooded (Long-Evans) rats, representing the 3rd generation to be fed diets
that were either deficient in, or supplemented with, omega-3 PUFA. ECG data
were obtained from surface electrodes and 4000 beats were analyzed for each
animal.
Results: Dietary manipulation, despite leading to large changes in tissue omega-
3 PUFA levels, did not significantly affect the complexity of heart rate dynamics,
with Hurst exponent (H) values of 0.15±0.02 and 0.12±0.03, for animals fed omega-
3 fatty acid-adequate and -deficient diets, respectively. Mean heart rate was also
unaffected by the diets. A power calculation revealed that about one hundred
animals per group would have been required to avoid a type II error.
Conclusions: According to this model of dietary PUFA manipulation, omega-3 fatty
acids are unlikely to exert a large effect on the autonomic functions that control
heart rate variability. Prospective studies into the effect of omega-3 fatty acids
on HRV should consider the need for large sample size as estimated by the results
contained in this report.
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Introduction
Moment-to-moment variation in heart rate, which reflects the influence
of autonomic tone on cardiac function, serves as a powerful prognostic
indicator for survival following myocardical infarction [1, 2]. Some studies
[3-7], but not all [8] suggest, in both healthy human adults, and survivors
of myocardial infarction (MI), a relationship between omega-3 PUFA content
in blood cells and altered heart rate dynamics. The above-mentioned studies
by Christensen and colleagues are in agreement that increased 
omega-3 levels are correlated with an increase in heart rate variability (HRV),
as measured using time-domain analyses, though the mechanisms that
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modulate these effects are yet to be elucidated.
However, these studies did not find increases in HRV
following short-term dietary supplementation with
omega-3 PUFA.
Heart rate dynamics are usually estimated using
parameters obtained from time-domain or
frequency-domain analyses [9, 10]. Results obtained
with these methods are confounded by the changing
statistical properties of heartbeat interval time-series
over time, i.e. non-stationary signals. These signals
are difficult to interpret with dispersional measures
in the time-domain, such as the standard deviation,
because the results are not stable with increasing
data length. Additionally, these measures do not give
any information regarding the internal dynamics of
the time-series. Frequency-domain measures rely on
assumptions of stationarity that are not met with
interbeat interval (IBI) data, especially with longer
recording times.
We have used a technique that measures the
internal dynamics of an IBI time-series by calculating
the Hurst exponent (H). The Hurst exponent is 
a direct measure of the dynamics of a time-series,
conceived by Hurst [11] and formalized by Mandelbrot
[12]. The value of H varies, with 0≤H≤1. Visual
inspection of a time-series with H=1.0 (as shown in
Figure 1C), reveals an overall relative smoothness to
the graph of IBI versus time. As H tends towards 0,
trends are more rapidly reversed (Figure 1B, H=0.05),
where there are large variations between adjacent
values, which give it a very irregular look. When H=0.5,
(Figure 1D), the magnitude of the sequential points
of the time-series are independent (of one another)
and therefore uncorrelated. The time-series can be
considered a random walk. Thus, H values
approaching 0.5 from either extreme are symptomatic
of a breakdown in the long-range correlations of the
heart interbeat interval signal. Inasmuch as these
long-term correlations are associated with cardiac
health [13], Hurst analysis of heart interbeat intervals
can provide a measure of cardiac signal complexity
in relationship to disease states, and, as in this study,
to differing neural fatty acid profiles, subsequent to
dietary manipulation. Furthermore, since the measure
H is not significantly altered by changes in data
length, statistical moments, or means of the signal
[14], it allows comparisons of cardiac signal
complexity measures between different studies.
Cardiac signal complexity is related to the
autocorrelation of the interbeat interval time-series.
The increased autocorrelation is manifested by
increased beat-to-beat variability for the time-series
as H approaches 0. For these time-series, the
parameter H corresponds to increased heart rate
variability (HRV). Note however that increased
autocorrelation is seen as H diverges from the value
0.5 (random walk) towards either 1 or 0. Therefore,
the degree of autocorrelation is relatively equivalent
to HRV measures only for time-series with 0≤H≤0.5.
The term HRV will be used as a descriptor of beat-
to-beat variability, in accordance with current usage.
For interbeat interval time-series, H is a measure of
both HRV as well as cardiac signal complexity.
Therefore, increases or decreases in H correspond
to decreases or increases in HRV, respectively.
A time-domain measure such as standard
deviation, a classic descriptor of variance in data,
does not always correlate with HRV. This is because
the relationship between each interbeat interval is
lost. This point is illustrated in Figure 1. All time-series
represented in Figure 1B-1D were generated, as
outlined in the methods, to have the same mean
and standard deviation as an IBI time-series
obtained from one rat, (mean±SD 154.9 ms ±8.3),
shown in Figure 1A. The time-series from the animal
had an associated H value of 0.05±0.02. By visual
inspection, the “roughness” of this time-series best
matches the synthesized IBI series from Figure 1B,
with H=0.05. It can also easily be seen that beat-to-
beat variability is highest as H approaches 0.
The current methodology allows a better
representation of the internal dynamics of the
system than can be obtained from simple
dispersional measures such as mean and standard
deviation. Inasmuch as a spectral transform of the
IBI data is not required prior to analysis, short
lengths of IBI data with differing statistical
characteristics can be compared.
We used this technique to determine H using IBI
time-series data obtained from rats raised on diets
that differed in the amount of omega-3 fatty acids
supplied in the diet. Since decreases in heart rate
variability (HRV) are associated with higher values
of H [14], we surmised that a higher H value would
characterize ECG data from omega-3 deficient rats
when compared with those raised on an omega-3
adequate diet. We are not aware of any other study
to assess the effects of severe omega-3 PUFA
deficiency on HRV using Hurst analysis.
Material and methods
Animals and diets
All procedures involving animals were conducted
in accordance with local Animal Care guidelines and
were approved by the NIAAA Animal Ethics Committee.
Animals in this experiment were raised on one of
two semi-purified diets (Table I). Dietary fats were
supplied by the supplementary oils added to the
diets, thus creating one diet deficient in omega-3
fatty acids (n-3 DEF), and the other omega-3
adequate with the addition of pre-formed DHA (n-3
ADQ). The assayed fatty acid compositions of both
experimental diets are given in Table II. Other details
regarding the composition of the salt and vitamin
mixes have been described previously [15].
Animals were successively raised for three
generations (F3), as previously reported by this and
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other laboratories [16-19]. Twelve (12) F3 male,
hooded rats (Long-Evans) were used for the study
(though we failed to obtain data from one of the rats).
Animals were fed once per day with dietary pellets and
water ad libitum. The ambient light was cycled in the
animal room (12/12 light/dark cycle), with temperature
maintained at 70°F. Animals were 33 weeks old, and
matched for bodyweight at the time of testing (mean
±SD; n-3 DEF: 878±44 g; n-3 ADQ: 881±40 g).
Experimental procedure
ECG IBI data were collected as follows. Individual
rats were placed in an anesthesia chamber
containing isoflurane (Baxter, Deerfield, IL) for
approximately 30 seconds. Upon sedation, animals
were transferred to a downdraft table, where they
were maintained under anesthesia via a nose-cone.
The electrode positions corresponding to the
maximal QRS potential was determined using sub-
cutaneous needle electrodes, attached to a CD-200
oscilloscope monitor. Typically, this was 1 cm rostral
to the sternal notch, with a lateral separation of
approximately 3 cm either side of the midline. The
chest wall was shaven, and surface ECG electrodes
fixed with conductive gel and fast-setting glue. The
contact was further protected by tape and a custom-
made jacket and harness system that allowed
unrestricted movement upon waking. Animals were
allowed to awaken from anesthesia following the
setup procedure, which took 12-15 minutes.
Electrodes were wired to a Polar belt (Polar
Electro, Woodbury, NY), in communication with 
a Mini-logger Series 2000 (Mini-mitter, Sun River,
OR, USA), which was used to store the IBI data. The
logger configuration was adjusted in consultation
with the manufacturer to allow reliable capture of
IBIs corresponding to heart rates in the order of
400 beats per minute. The sampling rate for the
device is 500 Hz and results in a timing accuracy
of <1 ms in the measurement of the IBIs [20]. IBIs
were measured from the time of electrode contact
until 2 hours after awakening, such that
approximately 45,000 IBIs were recorded for each
animal. Following the recording period, animals
were briefly anesthetized again to enable removal
of the electrodes and harness. Soon after
completion of the HRV study, animals were
Figure 1. Illustration of the Hurst coefficient as it relates to cardiac IBI time-series. The ordinate-axis represents the IBI
in milliseconds (ms) and beat number is represented by the abscissa. The time-series B-D were synthesized according
to the methods to correspond with the H-value shown in the bottom right corner of each graph. The time-series
represented in A is from one rat used in the study, and the H-value is derived using Hurst analysis
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decapitated. Brain lipid composition was
determined using a lipid extraction method
modified after Schwertner [21], and fatty acid
analysis as described by Salem et al. [22]. As HRV
is primarily a measure of central function, cardiac
tissue was not obtained.
Data analysis
Cardiac IBI data, in milliseconds, were retrieved
from the Mini-Logger using Version 3.5 of the Mini-
Logger software on an IBM Pentium II personal
computer running Windows NT. The IBI data were
filtered using linear interpolation if any single IBI
was more than twice the magnitude of the
previous IBI. In most animals, the amount of
filtering required was less than 5% (range 0-10%;
mean±SEM, 3.8±1.4%). There were no differences
in filtering between the two experimental groups.
Data was analyzed as previously reported [14, 23]
using software incorporating an algorithm which
extracts the fractal dimension D of the time-series,
and derives the Hurst value as H=2–D. The software
application used for these analyses, running on
Windows NT, 95 or 98 (Microsoft, USA), is available
and can be obtained through a procedure outlined
at ftp://helix.nih.gov/pbdp.
The value of the embedding constant used for
the analysis was estimated by increasing the
embedding dimension in increments of 1 until D
reached a stable value. Empirical testing showed that
a dimension of 12 resulted in a stable measure of D
for all time-series tested.
H was determined for one continuous 4000 beat
sequence (approximately 10 minutes), which
commenced 90 minutes after the animal awoke. We
chose this period to enable maximal recovery from
anesthesia, while still maintaining a good surface
electrode contact. Analysis of variance (ANOVA) and
the Mann-Whitney sum of ranks were calculated
(Sigmastat, SPSS) to determine whether there were
differences in the values of H or IBI magnitude
between animals raised on the n-3 ADQ versus n-3
DEF diets.
Results
The r2-value for the linear regressions used for the
calculation of H values were all 1.00, suggesting that
a strong scale-dependent power law relationship [24]
applies to the hooded rat IBI time-series. The
Table I. Compostion of semi-synthetic diets Table II. Fatty acid composition of diets
Component (g/kg)
Casein, vitamin-free 200
Carbohydrate 600
Cornstarch 150
Sucrose 100
Dextrose 199
Maltose-Dextrin 150
Cellulose 50
Salt mix 35
Vitamin mix 10
L-Cystine 3
Choline bitartate 2.5
TBHQ 0.02
Fat 100
Fat sources (%) n-3 DEF n-3 ADQ
Coconut oil 81 74.49
Safflower oil 19 17.7
Flaxseed oil – 4.81
DHASCO – 3
Fatty acid n-3 DEF diet n-3 ADQ diet
8:0 0.8 2.1
10:0 3.8 3.9
12:0 39.7 35.3
14:0 16.7 15.5
16:0 9.8 9.5
18:0 9.7 9.0
20:0 0.2 0.2
22:0 0.1 0.1
24:0 0.1 0.1
Total saturated 80.8 75.7
16:1n-7 0.03 0.03
18:1n-9 3.5 4.4
18:1n-7 0.3 0.3
20:1 0.1 0.1
22:1 0.01 0.02
Total monounsaturated 3.9 4.8
18:2n-6 15.1 15.7
20:2n-6 0.05 0.06
Total n-6 15.1 15.8
18:3n-3 0.04 2.5
22:6n-3 – 1.3
Total n-3 0.04 3.8
18:2n-6/18:3n-3 345 6
n-6/n-3 346 4
Total PUFA 15 20
Values expressed as percentage of total fatty acid weight
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relationship of the IBI time-series and the calculated
H parameter is shown for one animal in Figure 2.
Heart rate was observed to increase (i.e. 
a decrease in IBI) as the animal recovered from
anesthesia, as shown in Figure 2. The observed
effects of isoflurane on heart rate variability are not
discussed in this report, and will be presented
elsewhere.
As shown in Table III, despite the profound
influence of the diets on the level of DHA in the
brain, the value for H was not affected. However, the
power of the ANOVA performed was far lower (0.05)
than that considered acceptable to avoid a Type II
error (i.e. 0.8). The sample size required to
adequately detect a significant difference was
calculated assuming a Normal distribution, equal
variances and a two-sided alternate hypothesis using
Equation 1,
in which n is the sample size required in each
group to detect a difference in mean H-value of Δ
(with α=0.05 and power (1–β)=0.8). σADQ and σDEF
are the standard deviations for measures of H in the
two diet groups. It was revealed that approximately
200 animals (100 from each dietary group) would
have been required for this study, in which Δ
represented a difference of approximately 20%.
Discussion
Changes in heart rate are primarily determined
by autonomic innervation, whereby parasympathetic
activation slows heart rate and sympathetic tone
increases it [25]. Hence, the moment-to-moment
variability of heart rate is an index of autonomic
nervous system function. One likely mediator of HRV
control is the type-3 serotonin receptor (5-HT3), since
pharmacological manipulations of this receptor’s
activity profoundly alter HRV [26]. Pronounced
changes in HRV have been found in various
disease states, most notably, alcoholism [23].
Moreover, assessment of HRV provides a means
of stratifying risk for sudden cardiac death, or
death following acute MI [27, 28]. Given the
importance of HRV as both an index of neural
integrity, and as a prognostic indicator in clinical
medicine, it is not surprising that the study of HRV
generators and the factors which may potentially
modulate them has attracted considerable
research interest [1, 2].
The present study assessed the effects of
extremes of tissue omega-3 PUFA on HRV, with the
neural omega-3 PUFA levels of those fed the
omega-3 deficient diet less than one-third that of
those fed the omega-3 adequate diet. Despite
these large differences, we failed to find 
a significant effect of dietary omega-3 fatty acids
on HRV (Table III). Furthermore, we did not find
an effect on heart rate, though others have
reported a decrease in HR with omega-3
supplementation [8, 29, 30]. Moreover, the study
would have required a large number of animals to
avoid a type II error.
Our results differ from some reports on humans,
following supplementation with dietary omega-3
fatty acids. The discrepancies may be explained by
several differences between this study and the
numerous human clinical trials, though aside from
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corresponding H-value (lower). Note the increase in
heart rate (decrease in IBI) following removal of
isoflurane anesthesia
(σ2ADQ +σ2DEF) × (Z1-α/2+Z1-β)
Δ2
n =
Diet Group
n-3 ADQ (n=5) n-3 DEF (n=6)
Brain DHA (% total lipid) 10.8±0.3* 3.4±0.5
H 0.15±0.04 0.12±0.07
Inter-beat interval (ms) 159.3±9.3 161.0±13.3
Heart rate (beats/min) 377.6±21.6 374.6±28.2
Values expressed as mean ±SD
*Greater than n-3 DEF (p<0.05)
Table III. Effect of diet on whole brain DHA, H, inter-beat interval and heart rate
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one clinical trial on survivors of myocardial
infarctions, positive associations between omega-3
fatty acids and higher HRV were only found after
post hoc analyses, which dichotomized the
treatment groups by plasma omega-3
concentrations [3-6, 31, 32]. The conclusions drawn,
though informative, are not definitive for several
reasons. Firstly it is well known that blood PUFA
profile does not necessarily reflect neural accretion
levels [33, 34], unless the level of consumption has
been maintained for some months. Rather, blood
cell PUFA profile is a reflection of the current (or recent
past) level of dietary fatty acid consumption. If HRV
was correlated with blood PUFA profile, one would also
expect a significant change with omega-3
supplementation in an interventional prospective
study. Hence, the conclusions made following
dichotomization are inconsistent with the failure to
find a treatment effect. Secondly, the reported
increases in the standard deviation of RR interval
(SDNN), as an indicator of increased HRV following
dietary omega-3 supplementation, did not consider 
a parallel increase in mean RR interval. Since the SDNN
is intrinsically related to the mean RR interval, increases
in the mean will necessarily increase the SDNN,
thereby confounding the interpretation of the results.
Additionally, our failure on finding a treatment effect
may be due to species differences in comparing
rodents and humans, and that our study did not
directly use dietary eicosapentaenoic acid, whereas
the human trials did. Furthermore, the experimental
models differed in that these rats were omega-3
deficient throughout neurodevelopment while the
human subjects were supplemented as adults.
Though ketamine is typically used in small animal
studies, it has been shown to exert marked effects
on N-methyl-D-aspartate (NMDA) receptors, which,
in turn, have been implicated in reflex control of
cardiac rhythm [26, 35, 36]. In contrast, isoflurane is
believed to act on γ-amino-butyric acid (GABA)
receptors, though its mechanism of action is unclear.
Furthermore, since isoflurane has very fast transport
clearance [37] and is not significantly metabolized
[38], we believe that our measures of HRV were not
significantly affected by anesthesia. Indeed, though
several reports have demonstrated generalized
power reductions for frequency-domain measures
of heart rate [39, 40], these do not appear to persist
following recovery [41].
Conclusions
We conclude that, according to this model of
dietary PUFA manipulation, omega-3 fatty acids are
unlikely to exert a large effect on the autonomic
functions that control heart rate variability. Prospective
studies into the effect of omega-3 fatty acids on HRV
should consider the need for large sample size as
estimated by the results contained in this report.
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